July 31, 2024 | Gut Health, Wellness
Özkan Ufuk Nalbantoğlu, Ph.D., CTO
Enbiosis transforms patient care with AI-powered microbiome analysis. After conducting a detailed analysis of the gut profile, Enbiosis AI provides a comprehensive report including wellness scores, disease risk predispositions, and personalized food and supplement recommendations. This enables practitioners to adopt a fully personalized approach. Enbiosis' clinically proven microbiome modulation tool enhances clinical outcomes by addressing the root causes of health problems through personalized nutrition. Ufuk earned his Ph.D. in Bioinformatics from the highly respected University of Nebraska-Lincoln. During his time at UNL, he excelled as a principal investigator in multiple NIH, NFS, and DTRA-funded projects, and he made a significant impact as a bioinformatics software architect for the Earth Microbiome Project. His research and development activities are focused on discovering novel microbial biomarkers and he holds three patents to his name on analysis and diagnostics of microbiome data.
Speakers: Özkan Ufuk Nalbantoğlu, Ph.D., CTO